MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway

被引:17
作者
Huang, Qingli [1 ]
Hou, Sen [2 ]
Zhu, Xiuqing [3 ]
Liu, Shouzhou [1 ]
机构
[1] Liaocheng Peoples Hosp, Dept Otorhinolaryngol Head & Neck Surg, 67 Dongchang West Rd, Liaocheng 252000, Shandong, Peoples R China
[2] Yanggu Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
[3] Chiping Peoples Hosp, Dept Otolaryngol, Liaocheng, Shandong, Peoples R China
关键词
miR-192; Nasopharyngeal carcinoma; RB1; PI3K; AKT pathway; CELL-PROLIFERATION; RETINOBLASTOMA PROTEIN; MIR-192; SUPPRESSES; TUMOR-SUPPRESSOR; CANCER CELLS; METASTASIS; INVASION; GROWTH; APOPTOSIS; PROGRESSION;
D O I
10.1186/s12957-020-1798-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The dysregulation of microRNAs (miRNAs) has been found in diseases and cancers, including microRNA-192 (miR-192). This study was designed to investigate the role of miR-192 in nasopharyngeal carcinoma (NPC) progression. Methods The expression levels of miR-192 and some genes were assessed by qRT-PCR and Western blot. The function of miR-192 was investigated through MTT, Transwell, and dual-luciferase reporter assays. Results The expression of miR-192 was increased in NPC tissues, and high miR-192 expression predicted poor prognosis in NPC patients. Functionally, upregulation of miR-192 promoted NPC cell migration, invasion, and growth. Furthermore, miR-192 activated EMT and PI3K/AKT pathway to regulate NPC progression. In addition, miR-192 directly targeted RB1 and suppressed its expression in NPC. Moreover, overexpression of RB1 weakened the promoted effect of miR-192 in NPC. Conclusion miR-192 promoted cell viability and metastasis in NPC through suppressing RB1 expression and activating PI3K/AKT pathway.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway
    Wu, J. -H.
    Tian, X. -Y.
    An, Q-M.
    Guan, X. -Y.
    Hao, C. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) : 1645 - 1652
  • [42] MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway
    Zhang, Wei
    Zhang, Qiu
    Cui, Qianbo
    Xu, Yu
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2023, 42
  • [43] PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
    Liu, Yang
    Yang, Siting
    Wang, Feng
    Zhou, Zheng
    Xu, Wenjing
    Xie, Jingjing
    Qiao, Linhui
    Gu, Yanglin
    ONCOLOGY LETTERS, 2021, 22 (01)
  • [44] Ginsenoside Rb1 promotes the growth of mink hair follicle via PI3K/AKT/GSK-3β signaling pathway
    Zhang, Haihua
    Su, Yongmei
    Wang, Jiantao
    Gao, Ying
    Yang, Fuhe
    Li, Guangyu
    Shi, Qiumei
    LIFE SCIENCES, 2019, 229 : 210 - 218
  • [45] LncRNA LOXL1-AS1 Promotes the Proliferation and Metastasis of Medulloblastoma by Activating the PI3K/AKT Pathway
    Gao, Ran
    Zhang, Rui
    Zhang, Cuicui
    Liang, Yingwu
    Tang, Weining
    ANALYTICAL CELLULAR PATHOLOGY, 2018, 2018
  • [46] MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway
    Dong, Yongqiang
    Liang, Guojun
    Yuan, Bo
    Yang, Chaoqun
    Gao, Rui
    Zhou, Xuhui
    TUMOR BIOLOGY, 2015, 36 (03) : 1477 - 1486
  • [47] lncRNA TYMSOS Promotes Epithelial-Mesenchymal Transition and Metastasis in Thyroid Carcinoma through Regulating MARCKSL1 and Activating the PI3K/Akt Signaling Pathway
    Jia, Jintang
    Liu, Yipeng
    Yang, Xiaogang
    Wu, Zhiqiang
    Xu, Xingwen
    Kang, Fugui
    Liu, Yifan
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2023, 33 (01): : 1 - 14
  • [48] β-Klotho Promotes the Development of Intrauterine Adhesions via the PI3K/AKT Signaling Pathway
    Guo, Zizhen
    Wang, Yuqing
    Wen, Xiaoyang
    Xu, Xinxin
    Yan, Lei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [49] RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways
    Lu, Huibin
    Jiang, Tian
    Ren, Kewei
    Li, Zongming
    Ren, Jianzhuang
    Wu, Gang
    Han, Xinwei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (01) : 217 - 225
  • [50] ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
    Ni, Sheng
    Wei, Qian
    Yang, Li
    ONCOTARGETS AND THERAPY, 2020, 13 : 12409 - 12419